Visualizar Tese - Instituto de Biociências - Unesp
Visualizar Tese - Instituto de Biociências - Unesp Visualizar Tese - Instituto de Biociências - Unesp
1005T 11p15.5 774,043-838,551 ANG 64509 CD151, CEND1, EFCAB4A, LRDD, PNPLA2, POLR2L,RPLP2, SLC25A22, SNORA52, TSPAN41015T 767,539-838,551 ANG 71013 CD151, CEND1, EFCAB4A, LRDD, PNPLA2, POLR2L,RPLP2, SLC25A22, SNORA52, TSPAN4642T_A 396,940-551,034 ANG 154095 ANO9, C11orf35, HRAS, LRRC56, PTDSS2, RASSF7,RNH1, SIGIRR733T_B 209,012-2,143,485 ANG 1934474 >10 hsa-mir-483, hsa-mir-675, hsa-mir-2101015T 11q13.1 65,775,949-65,880,765 ANG 104817 B3GNT1, BRMS1, CD248, CNIH2, KLC2, RAB1B, RIN1,TMEM151A, YIF1A954T 11q13.2 67,570,565-68,221,718 ANG 651154 C11orf24, CHKA, GAL, LRP5, SAPS3, SUV420H1,TCIRG1644T, 670T 11q14.1 82,275,057-83,407,676 ANG 1132620 ANKRD42, C11orf82, CCDC90B, DLG2, PCF11, PRCP,RAB30, SNORA70E681T 82,275,057-83,407,676 ANG 1132620 ANKRD42, C11orf82, CCDC90B, DLG2, PCF11, PRCP,RAB30, SNORA70E1015T 12p11.22-p11.21 30,581,792-31,656,430 ANG 1074639 CAPRIN2, DDX11, DENND5B, FAM60A, FLJ13224,IPO8, TSPAN111001T 12p13.31 7,530,089-9,042,700 ANG 1512612 >10733T_B 12q13.3 55,799,155-55,951,830 ANG 152676 LRP1, MIR1228, NDUFA4L2, NXPH4, R3HDM2, hsa-mir-1228SHMT2, STAC3842T 55,805,133-55,923,685 ANG 118553 LRP1, MIR1228, NDUFA4L2, NXPH4, SHMT2, STAC3 hsa-mir-1228300T_A 12q24.31 119,131,582-120,835,736 ANG 1704155 >101015T 12q24.33 131,666,252-132,065,341 ANG 399090 ANKLE2, CHFR, FBRSL1, GOLGA3, P2RX2, PGAM5,POLE, PXMP2, ZNF6051015T 13q14.11 39,854,438-40,523,146 ANG 668709 ELF1, FOXO1, LOC646982, MIR320D1, MIR621, hsa-mir-621, hsa-mir-
MRPS31, SLC25A15, SUGT1L1 320d-1630T_A 13q21.31-q21.32 61,500,686-65,823,692 ANG 4323007 OR7E156P, PCDH91015T 13q32.1 95,190,823-95,510,926 ANG 320104 DNAJC3, UGGT2630T_A 14q21.3-q22.1 46,294,392-48,524,187 ANG 2229796 MDGA21015T 14q22.1 49,863,385-50,450,539 ANG 587155 ABHD12B, ATL1, CDKL1, MAP4K5, NIN, PYGL, SAV1954T 14q23.1 57,617,329-58,746,271 ANG 1128943 ACTR10, ARID4A, C14orf37, DAAM1, DACT1,FLJ31306, KIAA0586, PSMA3, TIMM9, TOMM20L683T_B 15q26.1 89,659,483-90,416,121 ANG 756639 SLCO3A11015T 16q22.1 65,652,632-65,820,436 ANG 167805 >10 hsa-mir-328630T_A 16q22.3 72,033,508-72,894,835 ANG 861328 PSMD7631T_B 16q24.3 88,060,983-88,283,196 ANG 222214 ANKRD11, C16orf55, CDK10, CHMP1A, CPNE7,DPEP1, RPL13, SNORD68, SPG71015T 17q12 32,026,668-32,784,291 ANG 757624 AATF, ACACA, DHRS11, LHX1, MRM11015T 17q23.3-q24.1 59,409,954-60,286,002 ANG 876049 >101015T 17q25.3 74,300,696-74,491,524 ANG 190829 LGALS3BP, TIMP2, USP36733T_B 76,691,820-77,619,424 ANG 927605 >10 hsa-mir-1250, hsa-mir-338, hsa-mir-657630T_A 18q12.2 33,417,167-35,366,305 ANG 1949139 LOC647946733T_B 19q13.42 60,234,352-60,585,968 ANG 351617 >10629T_B 21p11.1 10,013,263-10,117,957 PH 104695 BAGE, BAGE2, BAGE3, BAGE4, BAGE5630T_A, 1003T 10,013,263-10,117,957 ANG 104695 BAGE, BAGE2, BAGE3, BAGE4, BAGE5733T_B 21q22.11 33,097,167-33,677,532 ANG 580366 C21orf54, C21orf62, IFNAR1, IFNAR2, IL10RB,OLIG1, OLIG2728T 21q22.12 35,234,989-36,070,842 ANG 835854 C21orf96, MIR802, RUNX1 hsa-mir-802733T_B 22q13.33 48,616,848-49,691,432 ANG 1074585 >10ANG = alto nível de ganhos; PH = perda homozigota; >10 = mais que 10 genes descritos na região.
- Page 215 and 216: Cirilo, PDRDISCUSSÃO192genômica/d
- Page 217 and 218: Cirilo, PDRDISCUSSÃO194identificar
- Page 219 and 220: Cirilo, PDRDISCUSSÃO196e também d
- Page 221 and 222: Cirilo, PDRDISCUSSÃO198O gene COL3
- Page 223 and 224: Cirilo, PDRDISCUSSÃO200resistênci
- Page 225 and 226: Cirilo, PDRDISCUSSÃO202bioquímica
- Page 227 and 228: Cirilo, PDRDISCUSSÃO204carcinoma c
- Page 229 and 230: Cirilo, PDRCONCLUSÕES DISCUSSÃO20
- Page 231 and 232: Cirilo, PDRREFERÊNCIAS2087. Refer
- Page 233 and 234: Cirilo, PDRREFERÊNCIAS210Brazelle
- Page 235 and 236: Cirilo, PDRREFERÊNCIAS212Churikov
- Page 237 and 238: Cirilo, PDRREFERÊNCIAS214Gannon BR
- Page 239 and 240: Cirilo, PDRREFERÊNCIAS216Holthause
- Page 241 and 242: Cirilo, PDRREFERÊNCIAS218Kazmiercz
- Page 243 and 244: Cirilo, PDRREFERÊNCIAS220Lloret M,
- Page 245 and 246: Cirilo, PDRREFERÊNCIAS222Mitra R,
- Page 247 and 248: Cirilo, PDRREFERÊNCIAS224Ozisik YY
- Page 249 and 250: Cirilo, PDRREFERÊNCIAS226Redon R,
- Page 251 and 252: Cirilo, PDRREFERÊNCIAS228Solyom S,
- Page 253 and 254: Cirilo, PDRREFERÊNCIAS230Ueki K, R
- Page 255 and 256: Cirilo, PDRREFERÊNCIAS232and poly(
- Page 257 and 258: Skubitz KM e Skubitz APJ Lab Clin M
- Page 259 and 260: Dimitrova IK et al. Fertil Steril,9
- Page 261 and 262: 317T_B317T_C13 614T 44 LU prolifera
- Page 263 and 264: 46 867T 46 LUM outros B 14 33,5 17
- Page 265: 1015T 6q13-q14.1 75,806,978-76,314,
- Page 269 and 270: 8q22.3-q23.1 105,831,966 107,742,33
- Page 271 and 272: Anexo 5. Genes identificados na an
- Page 273 and 274: + + CCDC8 0 51 37 14+ - CALM3 51 0
- Page 275 and 276: ABSTRACTBackground: Uterine leiomyo
- Page 277 and 278: Thus, these findings prompt us to i
- Page 279 and 280: Technologies, Santa Clara, CA). Sta
- Page 281 and 282: mapped at 1p36.13, 1q41, 2q32.1, 2q
- Page 283 and 284: genetic disorder showed the higher
- Page 285 and 286: The modulators were mainly associat
- Page 287 and 288: egulation of cell cycle. Chegini an
- Page 289 and 290: REFERENCES[1] Baird DD, Dunson DB (
- Page 291 and 292: [37] Luo X, Ding L, Xu J et al. (20
- Page 293 and 294: AArray CGHExpression arrayBtumoral
- Page 295 and 296: ABDiseases and Disorders P value Mo
- Page 298 and 299: Tabel 2. Genes identified on module
- Page 300 and 301: Table S1. Clinical parameters and h
- Page 302 and 303: 32 954T 45 M secretory W 12 33,7 18
- Page 304 and 305: 16 28184420-30915100 2730680 p11.2
- Page 306 and 307: MYPN hsa-miR-214 -NFKBIL2 - -PKP3 -
- Page 308: Table S5. Ingenuity Pathways Analys
MRPS31, SLC25A15, SUGT1L1 320d-1630T_A 13q21.31-q21.32 61,500,686-65,823,692 ANG 4323007 OR7E156P, PCDH91015T 13q32.1 95,190,823-95,510,926 ANG 320104 DNAJC3, UGGT2630T_A 14q21.3-q22.1 46,294,392-48,524,187 ANG 2229796 MDGA21015T 14q22.1 49,863,385-50,450,539 ANG 587155 ABHD12B, ATL1, CDKL1, MAP4K5, NIN, PYGL, SAV1954T 14q23.1 57,617,329-58,746,271 ANG 1128943 ACTR10, ARID4A, C14orf37, DAAM1, DACT1,FLJ31306, KIAA0586, PSMA3, TIMM9, TOMM20L683T_B 15q26.1 89,659,483-90,416,121 ANG 756639 SLCO3A11015T 16q22.1 65,652,632-65,820,436 ANG 167805 >10 hsa-mir-328630T_A 16q22.3 72,033,508-72,894,835 ANG 861328 PSMD7631T_B 16q24.3 88,060,983-88,283,196 ANG 222214 ANKRD11, C16orf55, CDK10, CHMP1A, CPNE7,DPEP1, RPL13, SNORD68, SPG71015T 17q12 32,026,668-32,784,291 ANG 757624 AATF, ACACA, DHRS11, LHX1, MRM11015T 17q23.3-q24.1 59,409,954-60,286,002 ANG 876049 >101015T 17q25.3 74,300,696-74,491,524 ANG 190829 LGALS3BP, TIMP2, USP36733T_B 76,691,820-77,619,424 ANG 927605 >10 hsa-mir-1250, hsa-mir-338, hsa-mir-657630T_A 18q12.2 33,417,167-35,366,305 ANG 1949139 LOC647946733T_B 19q13.42 60,234,352-60,585,968 ANG 351617 >10629T_B 21p11.1 10,013,263-10,117,957 PH 104695 BAGE, BAGE2, BAGE3, BAGE4, BAGE5630T_A, 1003T 10,013,263-10,117,957 ANG 104695 BAGE, BAGE2, BAGE3, BAGE4, BAGE5733T_B 21q22.11 33,097,167-33,677,532 ANG 580366 C21orf54, C21orf62, IFNAR1, IFNAR2, IL10RB,OLIG1, OLIG2728T 21q22.12 35,234,989-36,070,842 ANG 835854 C21orf96, MIR802, RUNX1 hsa-mir-802733T_B 22q13.33 48,616,848-49,691,432 ANG 1074585 >10ANG = alto nível <strong>de</strong> ganhos; PH = perda homozigota; >10 = mais que 10 genes <strong>de</strong>scritos na região.